chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shortly after the dose, I had fatigue Over the next 12-36 hours, I experienced full body aches, extreme fatigue, fever and chills Had to call in sick for work It resolved after 48 hours
having nosebleeds all over the place; This is a spontaneous report from a contactable consumer (patient's mother). A male patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown), via an unspecified route of administration on an unspecified date as dose number: Unknown, as single dose for COVID-19 immunization. Medical history included travel to foreign country. The patient's concomitant medications were not reported. The patient experienced having nosebleeds all over the place on an unspecified date in 2021. The clinical course was described as follows: On 11Aug2021, the patient's mother reported that her son (the patient) told her what happened to him after he had gotten the vaccine. She clarified that her son was put on programs doing (Place withheld) Cricket and had been out of the country so he was vaccinated at the place he went to. People were coming from (Place withheld) for a tournament. Therefore, every week or so, when he went to different Islands, he was tested by being swabbed in his nostril. He just came back home about 3 or so weeks ago. He was having nosebleeds all over the place. He previously has never had a nosebleed in his life. They had to rush him to a specialist who had to put a camera up his nose and burn it and close it and seal it up. He said it hurt. The specialist gave her son a card that said no one is to swab him until Pfizer tells them what is in the swab as well as the vaccination. The doctor said he is not allowed to have anyone swab his nose again. Therapeutic measure was received for the nosebleeds. The clinical outcome of the event, nosebleeds, was not reported.  The lot number for the vaccine, BNT162b2, was not provided and will be requested during follow-up.
Extreme Fatigue, Loss Of Smell and Taste Digestive Issues Severe Constipation Chronic Stomach Pains Anemia Vitamin Deficiencies Non Diabetic Hypoglycemia
Patient experienced dizziness on 11/2/21, 11/3/21 and 11/4/21. Dizziness resolved by 11/5/21
Arm swelling (4.5 cm), erythema, warmth, and tenderness at site of injection, No treatment, Symptoms starting this morning at 8 AM
Diagnosed on Tuesday positive Covid with home test; Diagnosed on Tuesday positive Covid with home test; Moderna Covid booster on 20Dec2022; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient received BNT162b2 (BNT162B2), on 19Jan2021 as dose 1, single (Lot number: EL3248), on 05Feb2021 as dose 2, single (Lot number: EL964), on 09Oct2021 as dose 3 (booster), single (Lot number: 301258A) and on 05May2022 as dose 4 (booster), single (Lot number: FK9893) at the age of 71 years for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 20Dec2022 as dose 5 (booster), single (Lot number: 023422A) for covid-19 immunisation. The patient's relevant medical history included: "Blood pressure" (unspecified if ongoing); "knee pain" (unspecified if ongoing); "sciatic, mostly left side sciatic" (unspecified if ongoing); "hysterectomy" (not ongoing), notes: complete hysterectomy in the 1990's.; "gallbladder removed" (not ongoing), notes: gallbladder removed in the 1990's; "appendix removed" (not ongoing), notes: appendix removed in the 1990's. Concomitant medication(s) included: LOSARTAN taken for blood pressure abnormal (ongoing); OXYCODONE taken for arthralgia, sciatica (ongoing); FLU VACCINE VII taken for influenza immunisation as dose number unknown, single; SHINGRIX taken for varicella immunisation as dose number unknown, single; PNEUMOCOCCAL VACCINE taken for pneumococcal immunisation as dose number unknown, single as dose number unknown, single. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 20Dec2022, outcome "unknown", described as "Moderna Covid booster on 20Dec2022"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2023, outcome "unknown" and all described as "Diagnosed on Tuesday positive Covid with home test". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (2023) Positive. Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical course: Caller mentioned last week she was diagnosed with Covid even though she got all the shots and boosters. The Covid was not a lot of mucous, it was a runny nose and cough. She had all Pfizer Shots and last booster and flu and shingle and both pneumonia vaccines. Shouldn't had taken it. It made her worse. Going through changes in her body that she didn't have before Covid. Doesn't like how she felt. Diagnosed on Tuesday positive Covid with home test started Paxlovid on Friday thinks it was 02Jun2023 or possibly 26May2023.  Didn't have covid this last week or last.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300225043 Same patient, different drug/ events;
Caregiver called stating child complains of seeing snakes. Anxiety and hallucinations.
headache, trouble breathing. unable stay awake, nausea,  large raised red patch 2 to 3 inches in diameter at injection site, swollen lymph nodes throat. brain fog, fever, chills. unable to perform daily tasks
A report was received from a health professional regarding 20 patients who had inadvertently received only half doses of Fluvirin. There were no adverse events reported. There was insufficient information to determine the reporter's causality assessment.
Almost immediately upon receiving the GARDASIL vaccine, our daughter began sleeping constantly. By 12/2014, she began collapsing with any strong emotions. She was diagnosed with narcolepsy with cataplexy. She had ZERO symptoms prior to this vaccine.
After the 1st dose of Moderna vaccine, the patient had a rash on her back, but after the 2nd dose the rash appeared on her back again and spread to the upper chest, neck, and behind the ears. She made an appointment with her primary care physician and was told it was an allergy to the shot.
In afternoon, felt aches, then nausea which got worse, with nausea came dizziness, weakness and headache. No vomiting or diarrhea. No coughing then. I lay down. Over the night, the nausea and headache worsened; when I rolled on my right side, it hurt. Still no couching yet. I had chills by now. I wanted to go to the ER, but I didn't want to wake my husband. In the early Am, I asked him to take me to the ER where they examined me. Then I had a 102.4 fever. My blood pressure was 79/56?; the ER doctors listened to my lungs and "heard something" leading to a CXR, which showed an obvious right sided pneumonia. Before the CXR, I started to cough up blood, mostly pink to orange stained sputum. This was the first time I actually started to cough. They treated me with IV fluids, anti metics and added antibiotics in the IV. I was in to ER for a few hours. They gave me a prescription for antibiotics which I have been taking. I am drinking fluids (as I always use to do).
Expired vaccine used; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in an 81-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 13-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported. Vaccine administered on 11 days after first puncture.   Most recent FOLLOW-UP information incorporated above includes: On 28-Sep-2021: Follow-up received on 29-Sep-2021 and contains no new information.; Sender's Comments: This is a case of expired product administered for this 81 year-old patient, unknown gender, with no medical history reported, with no associated adverse event reported at this time. The rechallenge is not applicable. The benefit-risk relationship of Moderna COVID-19 Vaccine  is not affected by this report.
Patient presented to the ED and was subsequently hospitalized for atrial flutter with rapid ventricular response within 6 weeks of receiving covid booster vaccination.
The mom states that her son was "damaged" by the vaccines and every time she would report the event to the Doctor, she was told that the reaction was "normal". The child was born almost a month early during a 25 hour delivery. He was not jaundiced and she breast fed him at birth. He received his first vax the day after he was born. Following the hepatitis vaccine she reported that the infant was making some unusual sounds, almost like a little lamb. He continued to make these sounds when they went home from the hospital and he also began to have problems with diarrhea and constipation. Following each vax he became irritable, wouldn't sleep and would run a fever. The Doctor insisted this was normal. When he was 18 months old he slowly started regressing. He experienced a lump in his leg which the MD said would go away. When he was 2 years old he was diagnosed with PDD and then later they changed it to Autism.
Patient received Hep B # 3, IPOL & typhoid vi in left arm on 9/8/11. C/O right calf pain and was ruled out for a DVT via ultrasound.
Patients guardian falsified DOB when registering for vaccination, stating the minor's DOB; guardian, consented to the vaccination. Department of Health verified with statistical records that the patients actual DOB; which made the vaccine a contraindication.  No known adverse reactions noted.
The evening of the 24th had a itchy pimply rash on face. It subsided.  The next night on 5/25/17 had a similar rash on neck and arm. All symptoms subsided after a few hours only to reappear the next day.  Patient reported on 5/26/17, has no further symptoms since.
got cold feet; This is a spontaneous report from Pfizer-sponsored program and a contactable consumer or other non-Health Care Professional. A female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and Expiry date: Unknown), dose 1 via an unspecified route of administration on 12Jan2021 as 1ST DOSE, SINGLE DOSE for covid-19 immunization. The patient's medical history was not reported. The patient's concomitant medications were not reported. The patient received first dose 12Jan2021 and on an unspecified the patient experienced got cold feet. The patient had missed second dose scheduled for 02Feb2021.The outcome of event was unknown.  Information about lot/batch number has been requested.
Case number PHEH2013US021425 is an initial spontaneous report received from a physician on 08 Oct 2013: This report refers to a 29-year-old female patient. Her vaccination history included administration of a flu vaccine following which she experienced aches and pains (see related case: PHEH2013US021218) in the previous year. She was vaccinated with a seasonal influenza vaccine (manufacturer and batch number) on an undetermined date and experienced aches and pains. The patient recovered on an unknown date. No further information about seriousness and causality was mentioned. The patient was subsequently vaccinated with another seasonal influenza vaccine the next year and experienced same reaction (see related case: PHEH2013US021426).
Patient became  disoriented incontinent extremely  high blood pressure lethargic  exhausted confused jumbled speech
Patient came in on June 26.2018 and showed a red area around the shot area. Pain said felt warm.  Size was about 3 to 4 inches in diameter.
Information has been received from a physician via company representative referring to a male patient of unknown age. The patient's pertinent medical history and drug allergies were not reported. On an unknown date the patient was vaccinated with a dose of GARDASIL (lot#, dose and strength unknown) subdermally. Later the patient died from bone cancer on an unknown date. It was unknown if autopsy was done. Causality was not provided. Additional information has been requested.
Pt received vaccine 02/23,2021. Pt had flu like symptoms day after shot. But today had dizziness/pre-syncopal episode.
I have a vague pain in my chest around my heart that radios towards my right arm. It also radios towards my right jaw. These symptoms have been going on since July. I went to my doctor about this. They did an EKG and a chest x-ray, normal results. He was unsure what was causing it.
This spontaneous report was received from a registered nurse referring to a 12 year old male patient. The patient's  concurrent conditions and medical history were not provided. On 22-JAN-2016, the patient was vaccinated with a first dose of GARDASIL 9, lot # L014415, expiration date on 25-JUL-2017 (route was not provided. Then; at the same day, the patient went to another clinic and was vaccinated with a second dose of GARDASIL 9 (route, lot number and expiration date were unspecified). Concomitant therapies were not provided. No adverse events were reported. No product quality complaint was involved. Additional information has been requested.
This is a spontaneous report from a contactable consumer via Pfizer sales representative, who reported same event for the four patients . This is the third of four reports. A female patient (age range reported as 50-70) receive a single dose of PREVNAR 13 , on an unspecified date as vaccination. The patient medical history and concomitant medications were not reported.  On an unknown date, few days after vaccination, the patient complained of soreness between the elbow and shoulder. There was redness as well.The outcome of the events was unknown; Sender's Comments: Linked Report(s) : US-PFIZER INC-2016487623 same reporter/drug/event, different patient
Patient experienced  high grade fever of 103 degrees F and was shaking and looked red and was weak in the legs (this happened 3 hrs after vaccination). they went to ER and was diagnosed w/ pneumonia
Narrative: Patient is an 87 yo MALE with PMHx significant for HTN, CAD (s/p CABG x4 with TAVR), Afib (on warfarin), OSA, and HLD. Patient received Pfizer COVID-19 vaccine dose #1 and #2 on 1/27/21 and 2/14/21 respectively. After second COVID-19 vaccination, pt (w/ daughter) requested for BP to be checked. Pt reported a few months of non-steady BP readings at home (4 hours after AM rx BP varies between 106-138/80 at times diastolic up to 90); stated he was taking listed BP meds w/ lisinopril in AM, questionable atenolol and no diuretic use. Denied chest pain, headache, or dyspnea. Per clinic provider's assessment, w/ BP of 164/99 mmHg (repeat 158/81), deemed it as essential HTN. With pt being in vaccine clinic w/  stress and home reading being reasonably in range, changes were not made to medications. Pt and daughter instructed to continue monitoring, take BP meds as prescribed, and to call in case of worsening BP; PCP team was alerted.
Light case of Bell Palsy. A couple of days after vaccination, I started noticing that there was a slight change to the left side of my face. My nose and I were giving me discomfort and when I tried to smile or eat, I was having difficulty with the left side of my face. I also noticed that I had some difficulty with accuracy when I tried to spit or trouble keeping my mouth fully closed when gurgling mouthwash. I visited the doctor's office after about a week and the doctor did notice a change on one side of my face and said it was Bell Palsy, but a very slight case of it. It was too late to start on steroids, but that it looked like it was already getting better on its own.
Several pts recvd 3 doses of Engerix-B & were determined to be non-responders;
This case was reported by an office manager for a physician's office and described the occurrence of hepatitis A antibody negative in a 26-year-old male subject who was vaccinated with hepatitis A vaccine (manufacturer unspecified) and hepatitis B vaccine. Previous and/or concurrent vaccination included Havrix (GlaxoSmithKline) unknown given on 2 May 2007; Engerix B (GlaxoSmithKline) unknown given 2 May 2007. In 2002, the subject received unspecified dose(s) of hepatitis A vaccine (unknown). The subject also received dose(s) of hepatitis B vaccine (unknown), but it was unknown when the series was administered. The subject received the hepatitis A and hepatitis B vaccines in Singapore. In 2002, less that one year after vaccination with hepatitis A vaccine and an unspecified time after vaccination with hepatitis B vaccine, a titer was taken to detect both hepatitis A antibodies and hepatitis B antibodies. The hepatitis A titers were negative and the hepatitis B titers were positive. Additional titers were taken on 01 May 2007 and both titers for hepatitis A and hepatitis B were negative. On 02 May 2007, the subject received booster doses of Havrix (GlaxoSmithKline) and Engerix B (GlaxoSmithKline). No additional titers had been taken at the time of reporting. At the time of reporting the outcome of the events was unspecified.
Day 1: Immediate reaction: soreness of arm, Approx 7 hours after the shot: violent chills, headache, sweats, body aches.  Nausea, vomiting, misery Day 2: Severely dizzy, jittery feeling, achy, exhausted, nauseous, Day 3: Dizzy, jittery, achy, low energy/exhaustion, mind spacey/unable to concentrate  Day 4: Continued dizziness & extremely easily exhausted, diarrhea Day 5 to 14 (today):  Side effects linger:  Weakness, Dizziness, especially when first standing up, Low energy, Thinking is slow, not sharp & concentration difficult, Equilibrium & balance feel off, Cannot drive due to dizziness & brain fog, headaches
This spontaneous report as received from a medical assistant (M.A.) refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 05-NOV-2015, the patient was vaccinated with the third dose of improperly stored ROTATEQ oral liquid (lot # L008574, expiration date 22-NOV-2016) (dose unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
This spontaneous report as received from health professional via company representative refers to a male patient of unknown age. Patients concurrent conditions and medical history were not reported. On an unknown date in July 2013, the patient was vaccinated with GARDASIL first dose, (dose unspecified). Concomitant therapy was unspecified. On an unknown date in September 2013, the patient experienced suicidality (hospitalization). The patient was hospitalized following suicidality. It was reported that the patient received second dose of GARDASIL on an unknown date in December 2013. No Product quality issue involved. The outcome of suicidality was unknown. The reporters causality assessment with the event suicidality and the therapy with GARDASIL was not reported. Additional information has been requested.
86y.o.  female w/ PMHx of AML, Endometrial cancer, HTN, Hypothyroidism, Afib on xarelto  CC of fatigue and fever, which has been going on for today.  Patient states that she did to test at home that came back positive for COVID-19.  Patient had an appointment with her oncologist who advised for her to come into the hospital for treatment. She was febrile, hypertensive and had mild cough without any hypoxia or pneumonia on CXR. She was seen by ID and oncologist. All options for acute covid infection in immunocompromised pt were discussed and pt decided conservative supportive care approach. She stayed a few days and fever went down and didn't have any clinical deterioration. She was discharged home.
This is a spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the left arm on 20Apr2021 at 12:45 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. Medical history included multiple sclerosis (MS), immunocompromised, type 2 diabetes mellitus, gastroparesis and penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient received unspecified concomitant medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 23Mar2021 at 13:00 (at the age of 62-years-old) as a single dose for COVID-19 immunisation. The patient previously took ciprofloxacin (CIPRO) for an unknown indication on an unknown date and experienced drug allergy. On 21Apr2021 at 04:00, the patient experienced a very sore arm. On 22Apr2021, two days later, the patient was covered in a hot, red rash on body, whole stomach and chest, arms, legs, back, buttocks. The vaccine site was red and swollen to the size of a softball. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events a very sore arm, covered in a hot, red rash on body, whole stomach and chest, arms, legs, back, buttocks, vaccine site was red and swollen to the size of a softball was not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
fever; chills; Headache; nausea; This case was reported by a consumer via interactive digital media and described the occurrence of fever in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 4th February 2022, the patient received Shingles vaccine. In February 2022, less than a week after receiving Shingles vaccine, the patient experienced fever, chills, headache and nausea. On 6th February 2022, the outcome of the fever, chills, headache and nausea were recovered/resolved.   It was unknown if the reporter considered the fever, chills, headache and nausea to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had the shot on Friday and the weekend was horrible from the side effects.  The patient experienced fever,chills,headache,nausea. It was Sunday afternoon (at the time of reporting) before the patient felt better.